
Raquel
Lieberman
PhD
Location
Atlanta, GA, USA
Current Organization
Georgia Institute of Technology
Biography
Raquel L. Lieberman received her bachelor of science degree in chemistry from the Massachusetts Institute of Technology in 1998, and her doctoral degree in chemistry from Northwestern University in Chicago (2005), where she worked with Prof. Amy C. Rosenzweig on biophysical and structural studies of an intramembrane metalloenzyme. After conducting postdoctoral work with Prof. Michael S. Wolfe (Center for Neurological Diseases, Harvard Medical School) and Prof. Gregory A. Petsko (Brandeis) where she expanded to molecular aspects of protein misfolding, she joined the faculty in the School of Chemistry and Biochemistry at Georgia Institute of Technology and is currently an associate professor. Research projects in Dr. Lieberman’s lab focus on molecular aspects of proteins implicated in misfolding disorders.
Grants
National Glaucoma Research
Understanding How Variants in LOXL1 Affect Pseudoexfoliation Glaucoma Risk
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Hannah Youngblood, PhD
Current Organization
Georgia Institute of Technology
National Glaucoma Research
Identification of Myocilin Posttranslational Modifications and Binding Partners Under Static and Glaucoma-Relevant Mechanical Stretch
Active Dates
July 01, 2016 - June 30, 2018

Principal Investigator
Raquel Lieberman, PhD
Current Organization
Georgia Institute of Technology
National Glaucoma Research
Development of Pharmacological Chaperone Therapy for Inherited Primary and Juvenile Open Angle Glaucoma
Active Dates
April 01, 2008 - March 31, 2011

Principal Investigator
Raquel Lieberman, PhD
Current Organization
Georgia Institute of Technology
News Featuring This Grantee

Research News
A Key Protein Could Alter Risk for Pseudoexfoliation Glaucoma
BrightFocus National Glaucoma Research-funded scientist Hannah Youngblood, PhD, is investigating the role of an important protein called LOXL1 to pave the way for new glaucoma treatments.

Research News
New Antibodies Help Uncover Myocilin’s Role in Glaucoma
Dr. Raquel Lieberman and colleagues develop antibodies that can detect human and mouse myocilin, a protein that, when misfolded, is involved in glaucoma.